Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Anal Canal HPV Infection in Patients with Crohn’s

Clin Gastroenterol Hepatol; ePub 2018 Mar 15; Vuitton, et al

One third of patients who underwent colonoscopy at a single gastroenterology department were found to have anal canal human papillomavirus (HPV) infection, with high-risk HPV (HR-HPV) infection in nearly 20% of patients and in a significantly higher proportion of patients with Crohn’s disease than without. Researchers analyzed anal tissue samples collected from 469 consecutive patients (mean age 54 years, 52% women), including 112 who received immunosuppressant therapies and 101 with inflammatory bowel disease (70 with Crohn’s disease), who underwent colonoscopy examinations from April 1, 2012 to April 30, 2015. They found:

  • HPV DNA in anal tissues was detected from 34% of participants and HR-HPV in 18%.
  • HPV16 was the most prevalent genotype.
  • HR-HPV was detected in a significantly higher proportion of samples from women (23.1%) than men (12.1%).
  • HR-HPV and HPV16 were also detected in a significantly higher proportion of patients with Crohn’s disease (30.0%) than without (18.1%).

Citation:

Vuitton L, Jacquin E, Parmentier AL, et al. High prevalence of anal canal high-risk human papillomavirus infection in patients with Crohn’s disease. [Published online ahead of print March 15, 2018]. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2018.03.008.